Daiichi Sankyo (OTCMKTS:DSNKY) Shares Gap Down – What’s Next?
by Doug Wharley · The Cerbat GemDaiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY – Get Free Report) gapped down prior to trading on Tuesday . The stock had previously closed at $19.05, but opened at $18.26. Daiichi Sankyo shares last traded at $18.31, with a volume of 17,951 shares traded.
Daiichi Sankyo Trading Down 4.5%
The stock’s 50 day moving average price is $18.47 and its 200-day moving average price is $21.22. The company has a quick ratio of 1.85, a current ratio of 2.69 and a debt-to-equity ratio of 0.18. The stock has a market capitalization of $34.48 billion, a PE ratio of 16.70, a PEG ratio of 0.96 and a beta of -0.04.
Daiichi Sankyo (OTCMKTS:DSNKY – Get Free Report) last announced its quarterly earnings data on Thursday, January 29th. The company reported $0.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.25 by $0.05. The firm had revenue of $3.65 billion during the quarter, compared to analysts’ expectations of $3.88 billion. Daiichi Sankyo had a net margin of 14.83% and a return on equity of 18.64%. On average, sell-side analysts expect that Daiichi Sankyo Co., Ltd. – Sponsored ADR will post 1.04 earnings per share for the current fiscal year.
About Daiichi Sankyo
Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.
Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.